🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications
Updated 04 Jul 2026 · HPRA open data

Irish Medicines Database

Every medicine authorised for the Irish market — 10,165 products with active substances, licence holders, dosage forms and prescription status.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9
4,720 results for “eu”
MedicineActive substanceLicence holderStatus
Edarbi 40 mg tablets
EU/1/11/734/005-008
Azilsartan medoxomil Takeda Pharma A/S
Edarbi 80 mg tablets
EU/1/11/734/009-011
Azilsartan medoxomil Takeda Pharma A/S
Edistride 10 mg film-coated tablets
EU/1/15/1052/006-010
Dapagliflozin propanediol monohydrate AstraZeneca AB
Edistride 5 mg film-coated tablets
EU/1/15/1052/001-005
Dapagliflozin propanediol monohydrate AstraZeneca AB
EDURANT 2.5 mg film-coated tablets
EU/1/11/736/002
Rilpivirine Janssen-Cilag International NV
EDURANT 25 mg film-coated tablets
EU/1/11/736/001
Rilpivirine hydrochloride Janssen-Cilag International NV
Efavirenz Teva 600 mg film-coated tablets
EU/1/11/742/001-010
Efavirenz Teva B.V.
Efavirenz/Emtricitabine/Tenofovir disoproxil Krka 600 mg/200 mg/245 mg film-coated tablets
EU/1/17/1263/001-002
Tenofovir disoproxil succinate, Efavirenz, Emtricitabine KRKA, d.d., Novo mesto
Efavirenz/Emtricitabine/Tenofovir disoproxil Mylan 600 mg/200 mg/245 mg film-coated tablets
EU/1/17/1222/001-002
Efavirenz, Tenofovir disoproxil maleate, Emtricitabine Mylan Pharmaceuticals Limited
Efavirenz/Emtricitabine/Tenofovir disoproxil Zentiva 600 mg/200 mg/245 mg film-coated tablets
EU/1/17/1210/001
Tenofovir disoproxil phosphate, Efavirenz, Emtricitabine Zentiva k.s.
Effentora 100 micrograms buccal tablets
EU/1/08/441/1-2
FENTANYL CITRATE Phoenix Labs
Effentora 200 micrograms buccal tablets
EU/1/08/441/3-4
FENTANYL CITRATE Phoenix Labs
Effentora 400 micrograms buccal tablets
EU/1/08/441/5-6
FENTANYL CITRATE Phoenix Labs
Effentora 600 micrograms buccal tablets
EU/1/08/441/7-8
FENTANYL CITRATE Phoenix Labs
Effentora 800 micrograms buccal tablets
EU/1/08/441/9-10
FENTANYL CITRATE Phoenix Labs
Efficib 50 mg/1000 mg film-coated tablets
EU/1/08/457/8-14
Sitagliptin phosphate, Metformin Hydrochloride Merck Sharp & Dohme BV
Efficib 50 mg/850 mg film-coated tablets
EU/1/08/457/1-7
Sitagliptin phosphate, Metformin Hydrochloride Merck Sharp & Dohme BV,
Efient 10 mg Film-coated tablet
EU/1/08/503/8-14
Prasugrel hydrochloride Substipharm
Efient 5 mg Film-coated tablet
EU/1/08/503/1-7
Prasugrel hydrochloride Substipharm
Efmody
EU/1/21/1549/003
Hydrocortisone Diurnal Europe B.V.
Efmody 10 mg modified-release hard capsules
EU/1/21/1549/002
Hydrocortisone Diurnal Europe B.V.
Efmody 5 mg modified-release hard capsules
EU/1/21/1549/001
Hydrocortisone Diurnal Europe B.V.
Eklira Genuair 322 micrograms inhalation powder
EU/1/12/778/001-003
Micronized aclidinium bromide Covis Pharma Europe B.V.
Ekterly 300 mg film-coated tablets
EU/1/25/1975/001-002
Sebetralstat Kalvista Pharmaceuticals (Ireland) Limited
Eladynos 80 micrograms/dose solution for injection in pre-filled pen
EU/1/22/1706/001
Abaloparatide Theramex Ireland Limited
ELAHERE 5 mg/mL concentrate for solution for infusion
EU/1/24/1866/001
Mirvetuximab soravtansine Immunogen Biopharma (Ireland) Limited
Elaprase 2 mg/ml concentrate for solution for infusion
EU/1/06/365/1-3
Idursulfase Takeda Pharmaceuticals International AG Ireland Branch
Elebrato Ellipta 92 micrograms/55 micrograms/22 micrograms inhalation powder, pre-dispensed
EU/1/17/1237/001-003
Fluticasone furoate, Umeclidinium bromide, Vilanterol trifenatate GlaxoSmithKline Trading Services Limited
Elfabrio 2 mg/ml Concentrate for solution for infusion
EU/1/23/1724/001-003
Pegunigalsidase Alfa Chiesi Farmaceutici S.p.A.
ELIGARD 22.5 mg powder and solvent for solution for injection
PA0812/005/002
Leuprorelin acetate Recordati Industria Chimica e Farmaceutica SpA Marketed
ELIGARD 22.5 mg powder and solvent for solution for injection
PPA2306/036/001
Leuprorelin acetate Originalis B.V.
ELIGARD 22.5 mg powder and solvent for solution for injection
PPA0465/511/001
Leuprorelin acetate PCO Manufacturing Ltd.
ELIGARD 22.5 mg powder and solvent for solution for injection
PPA25370/004/001
Leuprorelin acetate BModesto B.V.
ELIGARD 45 mg powder and solvent for solution for injection
PA0812/005/003
Leuprorelin acetate Recordati Industria Chimica e Farmaceutica SpA Marketed
ELIGARD 45 mg powder and solvent for solution for injection
PPA0465/511/002
Leuprorelin acetate PCO Manufacturing Ltd.
ELIGARD 45 mg powder and solvent for solution for injection
PPA2306/037/001
Leuprorelin acetate Originalis B.V.
ELIGARD 45 mg powder and solvent for solution for injection
PPA25370/001/002
Leuprorelin acetate BModesto B.V.
ELIGARD 7.5 mg powder and solvent for solution for injection
PA0812/005/001
Leuprorelin acetate Recordati Industria Chimica e Farmaceutica SpA Not marketed
Eliquis 0.15 mg granules in capsules for opening
EU/1/11/691/016
Apixaban Bristol-Myers Squibb/Pfizer EEIG
Eliquis 0.5 mg coated granule in sachet
EU/1/11/691/017
Apixaban Bristol-Myers Squibb/Pfizer EEIG
Eliquis 1.5 mg coated granule in sachet
EU/1/11/691/018
Apixaban Bristol-Myers Squibb/Pfizer EEIG
Eliquis 2 mg coated granule in sachet
EU/1/11/691/019
Apixaban Bristol-Myers Squibb/Pfizer EEIG
Eliquis 2.5 mg film-coated tablets
EU/1/11/691/001-005, 013
Apixaban Bristol-Myers Squibb Pharma EEIG
Eliquis 5 mg film-coated tablets
EU/1/11/691/006-012
Apixaban Bristol-Myers Squibb Pharma EEIG
ellaOne 30 mg film-coated tablet
EU/1/09/552/003
Ulipristal acetate Laboratoire HRA Pharma
ellaOne 30 mg tablet
EU/1/09/522/001
ULIPRISTAL (INN) Laboratoire HRA Pharma
Ellura hard capsules
TR22953/001/001
Laboratoire Pharmaceutique Pharmatoka SAS
elmiron 100 mg capsules, hard
EU/1/17/1189/001-002
Pentosan Polysulfate Sodium bene-Arzneimittel GmbH
ELOCTA 1000 IU powder and solvent for solution for injection
EU/1/15/1046/004
Efmoroctocog alfa Swedish Orphan Biovitrum AB
ELOCTA 1500 IU powder and solvent for solution for injection
EU/1/15/1046/005
Efmoroctocog alfa Swedish Orphan Biovitrum AB
19 20 21 22 23 24 25
Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 15 August 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.